ストックスクリーナーアプリを入手
3.0403
27.12%
0.6803
前日終値:
$2.36
開ける：
$3.2
24時間の取引高:
2.54M
Relative Volume:
66.65
時価総額：
$N/A
収益：
$507.90K
当期純損益:
$-32.18M
株価収益率:
-0.1387
EPS:
-21.9125
ネットキャッシュフロー:
$-31.81M
1週間 パフォーマンス:
+27.12%
1か月 パフォーマンス:
-62.11%
6か月 パフォーマンス:
-64.22%
1年 パフォーマンス:
-87.42%
1日の値動き範囲:
$2.795
$3.8563
1週間の範囲:
$2.795
$3.8563
52週間の値動き範囲:
$2.795
$3.8563
Co Diagnostics Inc Stock (CODX) Company Profile
Compare CODX vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
3.03 | 0 | 507.90K | -32.18M | -31.81M | -21.91 |
|
ABT
Abbott Laboratories
|
110.49 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
347.32 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.08 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.09 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.70 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-08-12 | ダウングレード | Sidoti | Buy → Neutral |
| 2021-12-29 | 開始されました | Sidoti | Buy |
| 2021-03-29 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-05-20 | アップグレード | Maxim Group | Hold → Buy |
| 2020-05-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-03 | ダウングレード | Maxim Group | Buy → Hold |
すべてを表示
Co Diagnostics Inc (CODX) 最新ニュース
Co-Diagnostics Regains Nasdaq Compliance and Listing Status - TipRanks
Co-Diagnostics regains Nasdaq listing compliance - Investing.com
Co-Diagnostics regains Nasdaq listing compliance By Investing.com - Investing.com UK
Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements - PR Newswire
Fundamentals Check: Will Co Diagnostics Inc benefit from rising consumer demandJuly 2025 Gainers & Daily Momentum Trading Reports - baoquankhu1.vn
CODX Stock Jumped A Whopping 148% Today: What’s Driving The Super Rally? - Stocktwits
Establishment Labs and Co-Diagnostics: A Comparison of Medical Companies - National Today
Inside Dubai's World Health Expo, Co-Diagnostics meets MENA lab leaders - Stock Titan
India grants license for CoSara PCR device; TB, HPV tests pending - Stock Titan
Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform - Morningstar
Co-Diagnostics (CODX) Downgraded to Hold by Maxim Group Today | - GuruFocus
Co-Diagnostics Shares Transition to Over-the-Counter Trading - AD HOC NEWS
Co-Diagnostics Faces Nasdaq Delisting After Bid Price Noncompliance - The Globe and Mail
CODX Stock Price, Forecast & Analysis | CO-DIAGNOSTICS INC (NASDAQ:CODX) - Chartmill
Co-Diagnostics (CODX) Price Target Increased by 2,900.00% to 38.25 - Nasdaq
Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market By Investing.com - Investing.com India
Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market - Investing.com Nigeria
Co-Diagnostics Received Notice of Delisting - TradingView — Track All Markets
Co-Diagnostics, Inc.(OTCPK: CODX) dropped from NASDAQ Composite Index - marketscreener.com
Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships - StreetInsider
Why Co Diagnostics Inc. stock could be next big winnerShare Buyback & Stepwise Trade Execution Plans - Улправда
CODX stock plunges to all-time lows on 1-for-30 reverse stock split approval - MSN
Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention and Expo on Oct 2-3 - marketscreener.com
CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform - Finviz
Co-Diagnostics Approves Reverse Stock Split to Maintain Listing - The Globe and Mail
Co-Diagnostics announces 1-for-30 reverse stock split - Yahoo Finance
Institution Moves: Is Co Diagnostics Inc stock a buy in volatile marketsDip Buying & Daily Volume Surge Trade Alerts - moha.gov.vn
Co-Diagnostics (CODX) Announces 1-for-30 Reverse Stock Split - GuruFocus
Co-Diagnostics to Effect a 1-for-30 Reverse Stock Split - MarketScreener
CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval - Stocktwits
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split By Investing.com - Investing.com South Africa
Co-Diagnostics announces 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split - Investing.com Canada
Co-Diagnostics Announces Reverse Stock Split - Financial Times
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies - The Malaysian Reserve
Co-Diagnostics Receives Grant of Australian Patent Covering Co-D - GuruFocus
Co-Diagnostics (CODX) Secures Australian Patent for PCR Platform - GuruFocus
Co-diagnostics receives Australian patent for PCR testing platform By Investing.com - Investing.com India
Co-diagnostics receives Australian patent for PCR testing platform - Investing.com
Co-Diagnostics Q3 2025 Earnings Preview - MSN
Can Co-Diagnostics Stock Recover If Markets Fall? - Trefis
Aug Breakouts: How resilient is Co Diagnostics Inc. stock in market downturns - Улправда
Co Diagnostics Inc (CODX) 財務データ
収益
当期純利益
現金流量
EPS
2.12%
1.12%
大文字化:
|
ボリューム (24 時間):